Intelligent Bio Solutions Inc.
INBS
$2.20
$0.020.92%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 607.50K | 872.30K | 727.80K | 823.80K | 764.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 607.50K | 872.30K | 727.80K | 823.80K | 764.10K |
| Cost of Revenue | 384.40K | 525.50K | -87.70K | 645.30K | 564.80K |
| Gross Profit | 223.10K | 346.80K | 815.60K | 178.50K | 199.20K |
| SG&A Expenses | 1.81M | 1.95M | 2.67M | 2.43M | 1.71M |
| Depreciation & Amortization | 305.20K | 300.40K | 284.50K | 318.90K | 290.30K |
| Other Operating Expenses | -133.60K | -126.10K | -77.90K | -83.80K | -153.20K |
| Total Operating Expenses | 2.87M | 3.60M | 3.54M | 3.78M | 2.76M |
| Operating Income | -2.26M | -2.73M | -2.81M | -2.95M | -1.99M |
| Income Before Tax | -2.26M | -2.69M | -2.80M | -2.99M | -1.98M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.26M | -2.69M | -2.80M | -2.99M | -1.98M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 7.30K | 9.20K | 11.10K | 9.10K | 6.70K |
| Net Income | -2.25M | -2.69M | -2.78M | -2.98M | -1.97M |
| EBIT | -2.26M | -2.73M | -2.81M | -2.95M | -1.99M |
| EBITDA | -2.02M | -2.48M | -2.58M | -2.69M | -1.76M |
| EPS Basic | -0.50 | -0.70 | -0.92 | -1.43 | -2.07 |
| Normalized Basic EPS | -0.31 | -0.44 | -0.57 | -0.89 | -1.29 |
| EPS Diluted | -0.50 | -0.70 | -0.92 | -1.43 | -2.07 |
| Normalized Diluted EPS | -0.31 | -0.44 | -0.57 | -0.89 | -1.29 |
| Average Basic Shares Outstanding | 4.54M | 3.81M | 3.04M | 2.08M | 949.70K |
| Average Diluted Shares Outstanding | 4.54M | 3.81M | 3.04M | 2.08M | 949.70K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
